167 related articles for article (PubMed ID: 38805059)
41. Isotretinoin systemic therapy and the shadow cast upon dermatology's downtrodden hero.
Lowenstein EB; Lowenstein EJ
Clin Dermatol; 2011; 29(6):652-61. PubMed ID: 22014987
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non-compliance: Survey among French-speaking health care professionals and patients in Belgium.
Lelubre M; Hamdani J; Senterre C; Amighi K; Peres M; Schneider MP; Bugnon O; De Vriese C
Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):668-673. PubMed ID: 29726056
[TBL] [Abstract][Full Text] [Related]
43. Important controversies associated with isotretinoin therapy for acne.
Wolverton SE; Harper JC
Am J Clin Dermatol; 2013 Apr; 14(2):71-6. PubMed ID: 23559397
[TBL] [Abstract][Full Text] [Related]
44. Dietary Supplements, Isotretinoin, and Liver Toxicity in Adolescents: A Retrospective Case Series.
DeKlotz CMC; Roby KD; Friedlander SF
Pediatrics; 2017 Oct; 140(4):. PubMed ID: 28864554
[TBL] [Abstract][Full Text] [Related]
45. Real-World Fetal Exposure to Acne Treatments in the United States: A Retrospective Analysis from 2006 to 2015.
Albogami Y; Sarayani A; Hincapie-Castillo JM; Winterstein AG
Drug Saf; 2021 Apr; 44(4):447-454. PubMed ID: 33683646
[TBL] [Abstract][Full Text] [Related]
46. Isotretinoin and iPledge: a view of results.
Maloney ME; Stone SP
J Am Acad Dermatol; 2011 Aug; 65(2):418-419. PubMed ID: 21763564
[No Abstract] [Full Text] [Related]
47. The cost of clear skin: balancing the social and safety costs of iPLEDGE with the efficacy of Accutane (isotretinoin).
Doshi A
Seton Hall Law Rev; 2007; 37(2):625-60. PubMed ID: 17294569
[No Abstract] [Full Text] [Related]
48. Accutane-exposed pregnancies--California, 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Jan; 49(2):28-31. PubMed ID: 10680601
[TBL] [Abstract][Full Text] [Related]
49. Gender differences in isotretinoin prescriptions during the COVID-19 pandemic at a U.S. academic medical center.
Duan GY; Ruiz de Luzuriaga AM
Arch Dermatol Res; 2023 Apr; 315(3):643-645. PubMed ID: 36149480
[TBL] [Abstract][Full Text] [Related]
50. Isotretinoin: controversies, facts, and recommendations.
Bauer LB; Ornelas JN; Elston DM; Alikhan A
Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1435-1442. PubMed ID: 27414637
[TBL] [Abstract][Full Text] [Related]
51. Isotretinoin for acne and rosacea.
Watson KD; Miest RY; Tollefson MM
Semin Cutan Med Surg; 2016 Jun; 35(2):79-86. PubMed ID: 27416313
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic inertia during isotretinoin treatment of juvenile acne by dermatologists, paediatricians and general practitioners.
Mahé E; Werner A; Cret L; Salinier C; Guellich A; Maruani A; Assathiany R;
Ann Dermatol Venereol; 2023 Mar; 150(1):39-45. PubMed ID: 36642678
[TBL] [Abstract][Full Text] [Related]
53. The power of Accutane. The benefits and risks of a breakthrough acne drug.
Meadows M
FDA Consum; 2001; 35(2):18-23. PubMed ID: 11444244
[No Abstract] [Full Text] [Related]
54. A novel patient support program to address isotretinoin adherence: proof-of-concept analysis.
Eichenfield LF; Krakowski AC
J Drugs Dermatol; 2015 Apr; 14(4):375-9. PubMed ID: 25844611
[TBL] [Abstract][Full Text] [Related]
55. A risk management program aimed at preventing fetal exposure to isotretinoin: retrospective cohort study.
Cheetham TC; Wagner RA; Chiu G; Day JM; Yoshinaga MA; Wong L
J Am Acad Dermatol; 2006 Sep; 55(3):442-8. PubMed ID: 16908350
[TBL] [Abstract][Full Text] [Related]
56. [Second joint position paper: Use of isotretinoin in severe acne].
Gómez-Flores M; Poletti-Vázquez DE; García-Hidalgo L; Fierro-Arias L; Herz-Ruelas M; Garza-Gómez J; Rosas-Ortiz JF
Rev Med Inst Mex Seguro Soc; 2019 Jan; 56(5):441-446. PubMed ID: 30777411
[TBL] [Abstract][Full Text] [Related]
57. Survey of Australian isotretinoin prescribing.
Lee ML; Cooper A
Australas J Dermatol; 1991; 32(1):13-6. PubMed ID: 1834043
[TBL] [Abstract][Full Text] [Related]
58. What is the best approach to reducing birth defects associated with isotretinoin?
Abroms L; Maibach E; Lyon-Daniel K; Feldman SR
PLoS Med; 2006 Nov; 3(11):e483. PubMed ID: 17121451
[TBL] [Abstract][Full Text] [Related]
59. Isotretinoin and the eye: A review for the dermatologist.
Ruiz-Lozano RE; Hernández-Camarena JC; Garza-Garza LA; Bustamante-Arias A; Colorado-Zavala MF; Cardenas-de la Garza JA
Dermatol Ther; 2020 Nov; 33(6):e14029. PubMed ID: 32683764
[TBL] [Abstract][Full Text] [Related]
60. Ethics of contraceptive counseling to minors on oral isotretinoin.
Adlam T; Grant-Kels JM; Farshchian M
Clin Dermatol; 2023; 41(1):127-128. PubMed ID: 36191665
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
